|
|
News
| 2007 | |
| May 15, 2007 |
DowpharmaSM Licenses Pfēnex Expression Technology™ to Biovel Life Sciences Private Limited | | May 01, 2007 |
DowpharmaSM Licenses PfēnexExpression Technology™to VGX Pharmaceuticals | | April 30, 2007 |
DowpharmaSM and Cygnus Technologies, Inc. Announce Launch of Pseudomonas fluorescens Host Cell Protein Kit | | February 27, 2007 |
Dow Global Technologies Inc. Announces License Agreement with Serum Institute of India Limited | | February 22, 2007 |
DowpharmaSM Announces Multi-Product License Agreement with Merck |
| 2006 | |
| April 10, 2006 |
DowpharmaSM Signs Fourth Collaboration Agreement In First Quarter of 2006 for Pfēnex Expression Technology™ | | April 07, 2006 |
DOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin | | February 28, 2006 |
VGX Pharmaceuticals and DowpharmaSM Sign Research and Development Agreement for VGX’s Lead Cancer Compound | | February 14, 2006 |
Viventia Biotech and DowpharmaSM Announce a Multi-Product Commercial License Agreement using Pfēnex Expression Technology™ from Dowpharma | |
|
